Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TapTalkTest: Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology

NCT06114914 is registered in ClinicalTrials.gov with University of Tasmania as lead sponsor.

NCT NCT06114914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06114914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TapTalkTest: Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology
Lead sponsor
University of Tasmania
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2022
Completion date
December 31, 2025
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, movement abnormalities, speech disorders